Viking Therapeutics Jumps 35.7% on Weight-Loss Drug Trial Data
Viking Therapeutics closed up 35.67% at $40.85 after VK2735 trial patients lost 16-19% of body weight. The real draw: less frequent dosing than current obesity drugs.
Topic
Weight Loss Drugs
Topic
Weight Loss Drugs
Proteinflation: Whey Prices Quadruple as Demand Outruns Supply
Whey protein costs more than four times its price three years ago, per Expana. Gym-goers now pay up to £170 a bag as demand from…